Hisun Pharmaceutical To Set Up Overseas Subsidiary
This article was originally published in PharmAsia News
Executive Summary
Zhejiang Hisun Pharmaceutical has announced plans to set up a wholly-owned subsidiary abroad; however, location details and investment amounts were not released. The team entrusted with managing the project will kick-start the plan depending on market conditions and the company's performance. Board members of Hisun believe the move will expand the firm's product sales globally, strengthen its drug registration work and help it stay abreast of the latest international business information. The establishment of a new overseas branch will raise the company's overall profit and risk-taking capacity. In addition, Hisun is reorganizing its management structure and implementing strategic business units to meet development needs. (Click here for more - Chinese Language)